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Histology 
 Adenocarcinoma 2208 46.3 246950 37.5
 Squamous 557 11.7 179428 27.3
 Large Cell 443 9.3 45796 7.0
 BAC 156 3.3 23836 3.6
 NSCLC 578 12.1 93666 14.2
 Other 827 17.3 68306 10.4
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Epidemiological study of lung cancer in western Mexico
Gurrola-Diaz, Carmen M.1 Gonzalez-Santiago, Ana E.1 Gonzalez-
Valencia, Jessica1 Santillan-Loza, Paola G.1 Plascencia-Ortiz, Teresita2 
Mendoza-Topete, Luz A.2 Troyo-Sanroman, Rogelio1 
1 Universidad de Guadalajara, Guadalajara, Mexico 2 Instituto Mexi-
cano del Seguro Social, Guadalajara, Mexico 
Objective: The aims of this study were to describe histological and 
clinical characteristics of lung cancer patients and its impact on diag-
nosis in the western region of Mexico over a period of four years and 
compare them with those historical series of other regions of Mexico 
and other countries.
Patients and methods: We studied retrospectively 1312 cases with 
clinical diagnosis of lung cancer, from the Department of pulmonary 
physiology (Western National Medical Center), from January 2002 to 
December 2005. Statistic analysis: Gender and age was compared with 
x2 test. Differences between diagnostic methods were established using 
comparative contingency tables. P value less than 0.05 was considered 
statistically signiﬁcant.
Results: Accordingly gender, 57% of lung cancer patients were men 
and 43% women. The average age was 51 years old. 14.3% had a 
deﬁnitive diagnosis of lung cancer. The average of analyzed samples 
for each patient was 1.67; nevertheless, there was cases with until 
8 samples. The average of patients with deﬁnitive diagnosis of lung 
cancer per year was 46.5 from 323. The most common histological 
type of lung cancer was adenocarcinoma (65%), followed by squamous 
cell lung cancer (20%). The most frequent diagnostic methods were: 
bronchial aspirate, pleural cytology and bronchial biopsy. Our study 
reveals statistical differences on frequency of lung cancer histological 
types compared with reports from Finland, Poland, Turkey, Spain and 
United States of America. Otherwise, the comparison between studies 
from other regions of our country and these results present similar 
frequencies.
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Overview of lung cancer in Dharmais National Cancer Hospital, 
Jakarta, Indonesia
Harsal, Asrul; Suratman, Eddy; Tambunan, Tagor 
Dharmais National Cancer Hospital, Jakarta, Indonesia
Background: Lung cancer is the ﬁrst cause of death in cancer patient, 
and Lung cancer mostly diagnosed at late stage, and survival was poor. 
To know the characteristic of lung cancer in our institution, we evalu-
ated lung cancer patient about, gender ratio, mean age, stage, type of 
cytology, distant metastatic, treatment and others.
Methods: From January 2004 to December 2004, we collected and 
analyzed the data ﬁles of lung cancer patient. This is the retrospective 
study, some data not completely.
Results: From total of 67 patients, 51 pts are man and 16 pts are 
woman, and average age 57 years old. The type of cancer are; SCLC 4 
% and NSCLC 96 %.
All SCLC are extensive stage, with brain metastatic, and NSCLC, stage 
IIIA; 2 %, IIIB; 46% and stage IV:52%.From the available data, cytol-
ogy ﬁndings are; Adenocarcinoma: 54 %, Squamous Cell Ca:22 %, 
Large cell Ca:4 %, and no describe the type of cytology: 20 %. Distant 
metastatic are bones: 19 pts, brain; 6 pts, liver; 5 pts, and contra lateral 
of lung: 5 pts. Chemotherapy was given to 23 pts (34 %), chemoradia-
tion for 2 pts (3%), and palliative radiotherapy for brain metastatic 
and bones;19 pts (28 %). Combination of chemotherapy was platinum 
based ( cisplatin or carboplatin) combined with etoposide, paclitaxel, 
gemcitabine, docetaxel, and irinotecan ) as ﬁrst or second line chemo-
therapy, one patients got Geﬁtinib after chemotherapy. 
Conclusion: Mostly diagnosis of lung cancer stage IIIB and IV. The 
type of cytology; Adenocarconoma is predominant, the four sites for 
metastatic are bones, liver, brain and lung, chemotherapy and target 
therapy was given for 34 % of patient.
P1-039 Epidemiology and Tobacco Control Posters, Mon, Sept 3 
Multiple carcinomas in the lung cancer patients
Jancarikova, Dana; Pesek, Milos 
Faculty of Medicine in Pilsen, Dept. of Tuberculosis and Resp. Dis-
eases, Pilsen, Czech Republic
Background: We have observed increasing rate of patients suffer-
ing from multiple primary carcinomas over the last ten years.The aim 
of this study was to ﬁnd signiﬁcant frequencies of various malignant 
tumour associations, as well as common risk factors, evaluation of 
therapy, prognosis and survival of patients with conﬁrmed lung cancer 
and additional primary malignancies.
Patients and Methods: This metastudy included 142 patients suffering 
from more than one primary carcinoma (synchronous or metachro-
nous appearance), where one of the tumours was histopathologically 
conﬁrmed lung cancer. Patients were registered in our department 
between 1995 and the fall of 2006. We have analysed their gender, age, 
family history, smoking status, date of the ﬁrst malignancy, as well as 
the timing of the secondary (or tertiary) malignancies. In addition we 
have observed the most frequent mutual associations of the tumours, 
outcome of therapy, survival rates, etc.
Results: There were 118 men and 24 women, age ranging from 26 to 
79 years. The longest interval between each carcinoma diagnoses was 
29 years (larynx and lung cancer) and 26 years (malignant lymphoma 
and lung cancer). The shortest interval corresponded to a simultaneous 
occurrence of lung cancer duplicity with different morphology. Median 
time interval between malignant tumours was 3 years.
Discussion: In our group predominance of men (83%) is evident, 
which could be explained by pre-selection of lung carcinoma be-
ing more common in men. 84% of patients were smokers (current or 
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former). 50% of patients had positive family history for general cancer 
occurrence. The mean age of patients at the time of the ﬁrst carcinoma 
diagnosis was 59 years, 63 years at second carcinoma and 64 years at 
a third carcinoma diagnoses. The most common duplicity according 
together with lung cancer in men was another lung cancer type, while 
in women it was cervical cancer.
Vast majority of patients were smokers (current or former), which cor-
responds to smoking being an important risk factor in head and neck, 
larynx, lung, urine bladder, kidney, cervix and colon cancers. In addi-
tion, complex genetic factors, such as inherited disease susceptibility 
though multiple DNA variations seem responsible of frequent positive 
family history of general cancer occurrence. The role of chemotherapy 
and radiotherapy in the primary carcinoma treatment should be also 
considered as an independent risk factor for subsequent malignancies.
Conclusion The frequency of multiple carcinomas occurrence is 
steadily increasing over the past ten years. Paradoxically, gradual 
improvements in treatment efﬁciency directed at the primary tumor, 
gives opportunity for secondary carcinomas to develop. In addition to 
the possibility of disease relaps it is therefore very important to keep in 
mind an increased risk of a secondary malignity risk in oncologic pa-
tients. This study is further expected to be extended by other common 
risk analysis - including professional exposure, genetic and dietetics 
inﬂuence as well as other factors.
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Smoking habits and associated factors among the medical students 
of Shaheed Beheshti University of medical sciences in Tehran-Iran 
Kolahi, Ali A.; Tahmoreszadeh, Shahrokh 
Shaheed Beheshti University of Medical Sciences, Tehran, Iran
Background: There were large increases in smoking in developing 
countries, especially among males, over the last part of the 20th centu-
ry. While prevalence of tobacco use has declined in some high income 
countries, it is increasing in some low and middle income countries, 
especially among young people and women. Smoking causes substan-
tially increased risk of mortality from lung cancer and a range of other 
medical causes. Among industrialized countries, where smoking has 
been common, smoking is estimated to cause over 90% of lung cancer 
in men and about 70% of lung cancer among women. Worldwide, it is 
estimated that tobacco causes about 8.8% of deaths (4.9 million) and 
4.1% of DALYs (59.1 million). The rapid evolution of the tobacco 
epidemic is illustrated by comparing these estimates for 2000 with 
those for 1990: there are at least a million more deaths attributable to 
tobacco, with the increase being most marked in developing countries. 
For industrialized countries, with just over one-ﬁfth of the world’s 
population, tobacco is the leading risk factor, accounting for about 12% 
of all disease and injury burden (about 2.5% of cancer burden). The 
aim of this study was to estimate smoking habits and associated factors 
among the medical students of Shaheed Beheshti University of Medical 
Sciences in Tehran. 
Methods: A cross-sectional survey conducted on 720 medical students 
(400 women and 320 men) by choosing randomly in Shaheed Be-
heshti University. Data collected by anonymous and Self-administered 
questionnaires. It included questions about demographic characteristics, 
family characteristics, social contacts, smoking pattern and use of other 
substances. The Completed questionnaires were thrown in a box by 
themselves. Logistic regression was used to analyze the inﬂuence of 
different factors on the probability of a medical student being a smoker.
Results: This study revealed the following results among medical 
students of Shaheed Beheshti University of Medical sciences: Over-
all, 14.2% of the medical students (24.7% of men; 5.8% of women) 
currently and regularly smoked; 15.7% of smokers were single, 80.4% 
were married and 3.9% were divorced. 7.1% of smokers reported start-
ing smoking at primary school (aged 7-11 years), 12.5% at guidance 
school (aged 12-14 years), 37% at high school (aged 15-18 years) and 
43.4% at the university (aged over 19 years). 
Male gender, being single, the worse relationship between medical 
students’ parents, alcohol and drug use in students, drug use in students’ 
friends and the place where students lived were found to be signiﬁcant 
variables predicting regular smoking by multivariate logistic regression 
analysis. Family status, relationship with father, alcohol and drug use 
in students’ families, alcohol use in students’ friends and prayer were 
found not to have inﬂuence on regular smoking. 
Conclusion: Smoking still constitutes a major problem among medi-
cal students. This may be due to the addictive effect of smoking and 
other reasons. More effective interventions that reduce smoking in the 
medical students should be implemented immediately so that medical 
students (next physicians) will be better able to fulﬁll their function as 
role models for the general population.
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Background: The presence of EGFR mutations in NSCLC has strong-
ly associated with never-smoking history. SHS exposure is associated 
with higher risk of lung cancer. We have conducted this study to evalu-
ate the association between SHS exposure and likelihood of mutations 
in EGFR gene in NSCLC patients who had never smoked.
Methods: SHS exposure information from a total of 93 never smok-
ers (<100 lifetime cigarettes) with newly diagnosed primary NSCLC 
was obtained using a standardized questionnaire. Patients were asked 
whether they were regularly exposed to SHS at home or work places, 
respectively. Nucleotide sequencing of the kinase domain of EGFR 
(exons 18 to 21) was performed using nested PCR ampliﬁcation of 
individual exons. 
Results: Patient characteristics (n=93) included median age 57 years; 
female (n= 81); adenocarcinoma ± bronchoalveolar carcinoma (n= 82); 
EGFR mutation (1 mutation in exon 18 G719, 31 in-frame deletions 
in exon 19, 10 mutations in codon 858 in exon 21). Fifty-two (55.9%) 
of the patients reported having been exposed to SHS, including 46 
(49.5%) exposed at home and 13 (14.0%) exposed at work. The inci-
dence of EGFR mutations was not associated with female gender and 
adenocarcinoma histology. Patients with SHS exposure showed a trend 
towards lower incidence of EGFR mutations (36.5% vs. 56.1%, P= 
0.060) and a signiﬁcantly lower incidence of deletion mutations in exon 
19 (57.9% vs. 87.0%, P= 0.033). When the incidence of EGFR muta-
tions was compared, no difference between SHS exposure at home and 
